# Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells

> **NCT06798623** · PHASE1 · RECRUITING · sponsor: **The Methodist Hospital Research Institute** · enrollment: 15 (estimated)

## Conditions studied

- Anterior Cruciate Ligament Reconstruction

## Interventions

- **BIOLOGICAL:** Autologous Mesenchymal Stromal Cells

## Key facts

- **NCT ID:** NCT06798623
- **Lead sponsor:** The Methodist Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-24
- **Primary completion:** 2028-03
- **Final completion:** 2030-03
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798623, "Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06798623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*